# Comera Life Sciences Holdings, Inc. (CMRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CMRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 912.9K | $ -6.54M | $ -5.31M | $ 171.6K | $ -4.22M |
| 2022 | $ 707.2K | $ -20.11M | $ -42.88M | $ 775.0K | $ -6.25M |
| 2021 | $ 380.2K | $ -6.48M | $ -4.64M | $ 323.1K | $ -14.69M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.04 |
| Liabilities / Eq | -1.73 |
| Current Ratio | 0.90 |

## Other views

- [Metrics](https://sponda.capital/en/CMRA.md)
- [Charts](https://sponda.capital/en/CMRA/charts.md)
- [Compare](https://sponda.capital/en/CMRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.